Labcorp Holdings Inc. (LH) financial statements and ratios from SEC XBRL: revenue $14.5B (TTM), net margin 6.3%, revenue growth 7.2% YoY, P/E 24.6. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $13.95B |
| Revenue (TTM) | $14.5B |
| Net Margin | 6.3% |
| Operating Margin (TTM) | 10.7% |
| Net Debt / EBITDA | 2.5 |
| Revenue Growth (YoY) | 7.2% |
| EPS Growth (YoY) | 18.6% |
| FCF Growth (YoY) | 10.0% |
| P/E Ratio | 24.6 |
| EV / EBITDA | 11.8 |
| Price / Book | 3.18 |
| Price / Sales | 1.91 |
| FCF Yield | 4.5% |
| Altman Z-Score | 3.45 (safe) |
| Piotroski F-Score | 8/9 |
| Piotroski checks passed | 8 of 9 |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
LH overview · LH earnings · LH KPIs · LH documents · LH ownership · LH peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.